Dengue hemorrhagic fever (DHF) in the community can have an impact of panic, death, and reduced age of hope in the family. Research on the quality of life of DHF pediatric patient who got the treatment of crystalloid and colloid fluids has never been done before. The purpose of this study was to determine the quality of life of DHF pediatric patients who received crystalloids and colloids with PedsQL instruments. The study design was a cohort with block randomization. The inclusion criteria in this study were hospitalized DHF pediatric patients aged one month -18 years from February to May 2018. The exclusion criteria were DHF patients who came with referrals from other hospitals who had received fluid therapy. Research data include the length of stay (LOS) and quality of life score with the PedsQL questionnaire. The statistical analysis was using an independent ttest and the Mann Whitney test. The length of stay for the crystalloid group is five days longer than the colloid group, which is four days. From a total of 48 subjects studied, the score for the physical function of the crystalloid fluid group 84.54 ± 9.90 was higher than the colloid group of 77.58 ± 19.30 (p = 0.125). The emotional functions in the crystalloid group obtained a score of 81.88 ± 12.14 higher than the colloid group, i.e., 79.17 ± 18.5 (p = 0.552). The social function in the crystalloid group had a score of 92.08 ± 8.84 higher than the colloid group of 86.67 ± 13.96 (p = 0.232). The school functions in the crystalloid group had a score of 50.42 ± 33.68 higher than in the colloid group of 37. 92 ± 36.62 (p = 0.225). The results of this study showed that the crystalloid group had a higher quality of life score compared to the colloid group, although it was not significant.

AbstrakDemam berdarah dengue (DBD) merupakan penyakit yang disebabkan oleh virus dengue yang ditularkan melalui gigitan nyamuk Aedes aegypti. Kunci keberhasilan terapi pada penyakit demam berdarah adalah pemberian cairan termasuk jenis dan jumlahnya. Dari aspek biaya terapi, cairan koloid diketahui lebih mahal dibandingkan cairan kristaloid. Tujuan dari penelitian ini adalah untuk mengetahui efektivitas biaya terapi cairan kristaloid dan koloid pada pasien anak demam berdarah periode Januari 2018 sampai Juni 2018 di Rumah Sakit PKU Muhammadiyah Bantul. Penelitian ini menggunakan desain penelitian eksperimental single blind randomized clinical trial. Sejumlah 48 pasien anak yang memenuhi syarat inklusi dibagi menjadi dua kelompok yaitu kelompok intervensi (n=24) yang mendapatkan terapi cairan koloid berupa inisial cairan gelafusal dan kelompok kontrol (n=24) yang mendapatkan terapi cairan kristaloid tunggal berupa ringer laktat. Data efektivitas (lama rawat inap) dan total biaya medis dianalisis menggunakan independent t-test dan rumus average cost-effectiveness ratio (ACER). Terdapat perbedaan yang signifikan lama rawat inap antara kelompok cairan kristaloid dibandingkan kelompok cairan koloid (p<0,05). Hasil penelitian menunjukkan perbandingan nilai ACER yaitu nilai ACER kelompok koloid (Rp28.560/efektivitas) lebih rendah dari nilai ACER kelompok kristaloid (Rp62.328/ efektivitas). Kesimpulan dari penelitian ini adalah terapi cairan koloid lebih cost-effective dibandingkan cairan kristaloid. AbstractDengue hemorrhagic fever (DHF) is a disease caused by the dengue virus which is transmitted through the bite of the Aedes aegypti mosquito. The key to the success of therapy in dengue fever is the administration of fluids including types and quantities. Based on its cost, colloid fluid therapy are known to be more expensive than crystalloid fluid therapy. The purpose of this study was to determine the costeffectiveness of crystalloid and colloid fluid therapy in dengue fever patients in the period of January-June 2018 at PKU Muhammadiyah Hospital Bantul. This study employed an experimental single blind randomized clinical trial design. A total of 48 pediatric patients who met the inclusion requirements were divided into two groups, namely the intervention group (n=24) who received colloid fluid therapy in the form of initial gelafusal fluid and control group (n=24) who received single crystalloid fluid therapy in the form of ringer lactate. Effectiveness data (length of stay) and total medical costs were analyzed using independent t-test and the average cost-effectiveness ratio (ACER) formula. There was a significant difference in length of stay between groups of crystalloid fluid compared to the group of colloid fluid (p<0.05). The ACER values of the colloid group (28,560 IDR/effectiveness) was lower than the crystalloid group (62,328 IDR/effectiveness). The conclusion of this study is that colloid fluid therapy group is more cost-effective than crystalloid fluid group.

Penyakit kronis pada lansia bertanggung jawab atas beban ekonomi yang signifikan yang timbul dari biaya perawatan kesehatan langsung dan hilangnya produktivitas karena sakit. Lansia merupakan kelompok non produktif yang ada di masyarakat. Support sosial diperlukan guna meningkatkan kualitas hidup selama hidupnya. Pengabdian masyarakat dilakukan guna meningkatkan pengetahuan mengenai pemanfaatan bahan alami guna pencegahan penyakit kronik , dan meningkatkan kualitas hidup lansia. Program senam lansia dan screening kesehatan yang dilakukan bertujuan sebagai deteksi dini tingkat kesehatan lansia. Metode dilakukan dengan ceramah dan partisipasi kelompok. Kegiatan dilaksanakan pada 22 Juli 2022 di RSUD Wonosari. Sasaran kegiatan ini adalah lansia di Wonosari. Hasil didapatkan, terdapat 66 partisipan dengan mayoritas  laki-laki  yang berusia  rata-rata 71-75 tahun. Rata-rata tekanan darah adalah 140/90 – 160/100 mmHg. Kadar gula darah mayoritas adalah 160 – 200mg/dl. Peserta mampu memahami gambaran pemanfaatan obat alami sebanyak 87 % , dan memiliki refleksi kualitas hidup yang tinggi  sebanyak 95 % setelah diberikan edukasi.

Background: Diabetes mellitus (DM) is a chronic disease with multiple aetiologies characterized by an increase in blood glucose levels exceeding normal limits. The world health organization predicts an increase in people with DM2 in Indonesia from 8.4 million to 21.3 million in 2030. Diabetes mellitus is one of the ninth main causes of decreased life expectancy, so it will greatly affect the quality of life of a person suffering from DM. Several factors that affect the quality of life of DM patients include age, gender, length of suffering, complications, education, marital status, level of compliance and occupation.Methods: This type of research is descriptive research with total sampling and obtained a sample of 26 respondents. Measurement of quality of life using the SF-36 instrument then the results were analysed using the chi square test to see the relationship between the factors that affect the quality of life.Results: The results obtained statistically that the complication factor (p=0.189) and the control frequency factor (p=0.596) did not significantly affect the quality of life. While the level of education statistically (p=0.006) affects the quality of life of DM patients.Conclusions: The results of the statistical study between complication factors and the frequency of control on the quality of life of DM patients showed no significant relationship. Meanwhile, the education level factor, both statistically and clinically, showed that there was a significant relationship with the quality of life of DM patients.